| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.63B | +29.2% |
| Cost of Revenue | $1.21B | +35.2% |
| Gross Profit | $2.41B | +26.4% |
| R&D Expense | $1.78B | +38.5% |
| SG&A Expense | $412.3M | +27.6% |
| Operating Income | -$1.46B | -33.0% |
| Pre-tax Income | -$1.29B | -51.3% |
| Income Tax | $4.1M | +136.6% |
| Net Income | -$1.29B |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.63B | +49.1% |
| Accounts Receivable | $922.8M | -0.4% |
| Current Assets | $5.87B | +16.5% |
| Total Assets | $9.03B | +9.9% |
| Current Liabilities | $3.30B | +20.9% |
| Total Liabilities | $6.03B | +98.7% |
| Stockholders' Equity | $3.00B | -42.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $959.8M | +13.2% |
| Capital Expenditures | $46.3M | +31.9% |
| Investing Cash Flow | $190.6M | -77.1% |
| Financing Cash Flow | -$226.5M | +73.5% |
| Free Cash Flow | $913.5M | +12.4% |
| -53.8% |
| EPS (Basic) | -$3.86 | -51.4% |
| EPS (Diluted) | -$3.86 | -51.4% |